🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety, tolerability, pharmacokinetics and immunogenicity o...
Status
Completed
Location
Quintiles
Start Date
2013-07-23
Trial ID
NCT01932242
This study is to evaluate the safety, local tolerability, pharmacokinetics ...
Status
Completed
Location
Covance Clinical Research Unit Inc.
Start Date
2013-07-26
Trial ID
NCT01932437
This field study is a post-marketing requirement from the FDA to evaluate t...
Status
Unknown
Location
Multiple Locations
Start Date
2023-12
Trial ID
NCT03088111
Treatments Being Tested
To evaluate the safety and tolerability and pharmacokinetics (PK) of a sing...
Status
Completed
Location
Covance Clinical Research Inc.
Start Date
2013-07-09
Trial ID
NCT01929226
Evaluate the safety, tolerability and pharmacokinetics (PK) of intravenous ...
Status
Completed
Location
Quintiles
Start Date
2013-10-29
Trial ID
NCT01952444
Treatments Being Tested
Title: Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Phase ...
Status
Completed
Location
Osu, 5084 Graves 333 W Tenth Ave
Start Date
2009-02
Trial ID
NCT00829582
Treatments Being Tested
The purpose of this study is to evaluate the safety and pharmacokinetics (h...
Status
Completed
Location
Ohio State University
Start Date
2005-10
Trial ID
NCT00138411
Treatments Being Tested
This study will determine the safety and PK of a single IV dose of ETI-204 ...
Status
Completed
Location
Quintiles
Start Date
2011-10
Trial ID
NCT01453907
Treatments Being Tested